Literature DB >> 16871879

Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma.

G Evren Keles1, Edward F Chang, Kathleen R Lamborn, Tarik Tihan, Chih-Ju Chang, Susan M Chang, Mitchel S Berger.   

Abstract

OBJECT: To investigate the prognostic significance of the volumetrically assessed extent of resection on time to tumor progression (TTP), overall survival (OS), and tumor recurrence patterns, the authors retrospectively analyzed preoperative and postoperative tumor volumes in 102 adult patients from the time of the initial resection of a hemispheric anaplastic astrocytoma (AA).
METHODS: The quantification of tumor volumes was based on a previously described method involving computerized analysis of magnetic resonance (MR) images. Analysis of contrast-enhancing tumor volumes on T1-weighted MR images was conducted for 67 patients who had contrast-enhancing tumors. Measurements of T2 hyperintensity were obtained for all 102 patients in the study. The presence or absence of preresection enhancement, actual volume of this enhancement, and the percentage of preoperative enhancement as it relates to the total T2 tumor volume did not have a statistically significant relationship to TTP or OS. In addition to age, the volume of residual disease measured on T2-weighted MR images was the most significant predictor of TTP (p < 0.001), and residual contrast-enhancing tumor volume was the most significant predictor of OS (p = 0.003) on multivariate analysis. In contrast to low-grade gliomas, there was no statistically significant relationship between the extent of resection and histological characteristics at the time of recurrence, that is, tumor Grade III compared with Grade IV.
CONCLUSIONS: Data from this retrospective analysis of a histologically uniform group of hemispheric AAs treated in the MR imaging era suggest that residual tumor volumes, as documented on postoperative imaging studies, may be a prognostic factor for TTP and OS for this patient population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16871879     DOI: 10.3171/jns.2006.105.1.34

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  50 in total

1.  The benefit of surgical resection in recurrent glioblastoma.

Authors:  Michael A Vogelbaum
Journal:  Neuro Oncol       Date:  2016-02-10       Impact factor: 12.300

2.  Towards a genomic definition of completeness of resection?

Authors:  Michael A Vogelbaum
Journal:  Neuro Oncol       Date:  2014-01       Impact factor: 12.300

Review 3.  Awake surgery between art and science. Part I: clinical and operative settings.

Authors:  Andrea Talacchi; Barbara Santini; Francesca Casagrande; Franco Alessandrini; Giada Zoccatelli; Giovanna M Squintani
Journal:  Funct Neurol       Date:  2013 Jul-Sep

Review 4.  Operative techniques for gliomas and the value of extent of resection.

Authors:  Nader Sanai; Mitchel S Berger
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

5.  Novel Surgical Approaches to High-Grade Gliomas.

Authors:  Fahid Tariq Rasul; Colin Watts
Journal:  Curr Treat Options Neurol       Date:  2015-09       Impact factor: 3.598

6.  Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.

Authors:  Tomohiro Kawaguchi; Yukihiko Sonoda; Ichiyo Shibahara; Ryuta Saito; Masayuki Kanamori; Toshihiro Kumabe; Teiji Tominaga
Journal:  J Neurooncol       Date:  2016-07-11       Impact factor: 4.130

7.  Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection. Clinical article.

Authors:  Kaisorn L Chaichana; Aditya N Halthore; Scott L Parker; Alessandro Olivi; Jon D Weingart; Henry Brem; Alfredo Quinones-Hinojosa
Journal:  J Neurosurg       Date:  2010-06-04       Impact factor: 5.115

8.  Radical resection of focal brainstem gliomas: is it worth doing?

Authors:  Charles Teo; Timothy L Siu
Journal:  Childs Nerv Syst       Date:  2008-06-18       Impact factor: 1.475

9.  Diffusion imaging for therapy response assessment of brain tumor.

Authors:  Thomas L Chenevert; Brian D Ross
Journal:  Neuroimaging Clin N Am       Date:  2009-11       Impact factor: 2.264

10.  Choline-to-N-acetyl aspartate and lipids-lactate-to-creatine ratios together with age assemble a significant Cox's proportional-hazards regression model for prediction of survival in high-grade gliomas.

Authors:  Ernesto Roldan-Valadez; Camilo Rios; Daniel Motola-Kuba; Juan Matus-Santos; Antonio R Villa; Sergio Moreno-Jimenez
Journal:  Br J Radiol       Date:  2016-09-14       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.